Ambrx, Inc. IPO Research Information

Ambrx, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Ambrx, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Ambrx, Inc.	AMBX - NASDAQ	$12.00-$14.00	$0.00	$0.00	5.4 million
Underwriter(s): Stifel, Wells Fargo Securities
Co-Manager(s): Canaccord Genuity, Needham & Company, Roth Capital Partners
Industry:
Filing(s): Filed 2014-05-03 Terms Added 2014-06-09

About Ambrx, Inc. (adapted from Ambrx, Inc. prospectus):
Ambrx is a clinical stage biotechnology company focused on discovering and developing first-in-class and best-in-class optimized protein therapeutics known as bio-conjugates.

This description is adapted from Ambryx, Inc., prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Ambryx, Inc., "AMBX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.